P/S - Newron Pharmaceuticals SpA (SIX:NWRN) - Alpha Spread

Newron Pharmaceuticals SpA
SIX:NWRN

Watchlist Manager
Newron Pharmaceuticals SpA Logo
Newron Pharmaceuticals SpA
SIX:NWRN
Watchlist
Price: 7.66 CHF -3.04%
Market Cap: 145.9m CHF
Have any thoughts about
Newron Pharmaceuticals SpA?
Write Note

P/S
Price to Sales

16
Current
10.3
Median
2.6
Industry
Higher than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
16
=
Market Cap
136.7m CHF
/
Revenue
9.1m EUR
All Countries
Close

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
6.4
2-Years Forward
P/S
6.6
3-Years Forward
P/S
7

See Also

Discover More